FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2158752020> ?p ?o ?g. }

• W2158752020 abstract "Diffusion of new cancer treatments can be both inefficient and incomplete. The uptake of new treatments over time (diffusion) has not been well studied. We analyzed the diffusion of docetaxel in metastatic prostate cancer. We identified metastatic prostate cancer patients diagnosed from 1995 to 2007 using the Surveillance, Epidemiology, and End Results Program (SEER)–Medicare database. Medicare claims through 2008 were analyzed. We assessed cumulative incidence of docetaxel by socioeconomic, demographic, and comorbidity variables, and compared diffusion patterns to landmark events including release of phase III results and FDA approval dates. We compared docetaxel diffusion patterns in prostate cancer to those in metastatic breast, lung, ovarian, and gastric cancers. To model docetaxel use over time, we used the classic “mixed influence” deterministic diffusion model. All statistical tests were two-sided. We identified 6561 metastatic prostate cancer patients; 1350 subsequently received chemotherapy. Among patients who received chemotherapy, docetaxel use was 95% by 2008. Docetaxel uptake was statistically significantly slower (P < .01) for patients older than 65 years, blacks, patients in lower income areas, and those who experienced poverty. Eighty percent of docetaxel diffusion occurred prior to the May, 2004 release of phase III results showing superiority of docetaxel over standard-of-care. The maximum increase in the rate of use of docetaxel occurred nearly simultaneously for prostate cancer as for all other cancers combined (in 2000). Efforts to increase the diffusion of treatments with proven survival benefits among disadvantaged populations could lead to cancer population survival gains. Docetaxel diffusion mostly preceded phase III evidence for its efficacy in castration-resistant prostate cancer, and appeared to be a cancer-wide—rather than a disease-specific—phenomenon. Diffusion prior to definitive evidence indicates the prevalence of off-label chemotherapy use." @default.
• W2158752020 created "2016-06-24" @default.
• W2158752020 creator A5001373245 @default.
• W2158752020 creator A5027618882 @default.
• W2158752020 creator A5037848674 @default.
• W2158752020 creator A5041539801 @default.
• W2158752020 creator A5081974715 @default.
• W2158752020 creator A5091192260 @default.
• W2158752020 creator A5091772334 @default.
• W2158752020 date "2014-12-24" @default.
• W2158752020 modified "2023-09-30" @default.
• W2158752020 title "The Diffusion of Docetaxel in Patients With Metastatic Prostate Cancer" @default.
• W2158752020 cites W146517413 @default.
• W2158752020 cites W1591976443 @default.
• W2158752020 cites W1593442063 @default.
• W2158752020 cites W1854708637 @default.
• W2158752020 cites W1893347245 @default.
• W2158752020 cites W1924763827 @default.
• W2158752020 cites W1932317695 @default.
• W2158752020 cites W1966978530 @default.
• W2158752020 cites W1973702706 @default.
• W2158752020 cites W1978099430 @default.
• W2158752020 cites W1978315939 @default.
• W2158752020 cites W1982853521 @default.
• W2158752020 cites W1984697813 @default.
• W2158752020 cites W1984944851 @default.
• W2158752020 cites W1986442309 @default.
• W2158752020 cites W1992625003 @default.
• W2158752020 cites W1994736171 @default.
• W2158752020 cites W1997009145 @default.
• W2158752020 cites W2000445173 @default.
• W2158752020 cites W2003985632 @default.
• W2158752020 cites W2010812304 @default.
• W2158752020 cites W2011137211 @default.
• W2158752020 cites W2014145760 @default.
• W2158752020 cites W2020238253 @default.
• W2158752020 cites W2022760931 @default.
• W2158752020 cites W2028565522 @default.
• W2158752020 cites W2032417785 @default.
• W2158752020 cites W2035505841 @default.
• W2158752020 cites W2039701204 @default.
• W2158752020 cites W2039953424 @default.
• W2158752020 cites W2041431725 @default.
• W2158752020 cites W2050948499 @default.
• W2158752020 cites W2057727832 @default.
• W2158752020 cites W2064370814 @default.
• W2158752020 cites W2067493741 @default.
• W2158752020 cites W2078118224 @default.
• W2158752020 cites W2080439368 @default.
• W2158752020 cites W2083074063 @default.
• W2158752020 cites W2085165820 @default.
• W2158752020 cites W2085811652 @default.
• W2158752020 cites W2089306366 @default.
• W2158752020 cites W2089823191 @default.
• W2158752020 cites W2102963284 @default.
• W2158752020 cites W2105216347 @default.
• W2158752020 cites W2108311269 @default.
• W2158752020 cites W2108326787 @default.
• W2158752020 cites W2116903603 @default.
• W2158752020 cites W2116956631 @default.
• W2158752020 cites W2117520220 @default.
• W2158752020 cites W2118167058 @default.
• W2158752020 cites W2118820600 @default.
• W2158752020 cites W2118931946 @default.
• W2158752020 cites W2120292596 @default.
• W2158752020 cites W2120298895 @default.
• W2158752020 cites W2134066118 @default.
• W2158752020 cites W2143246903 @default.
• W2158752020 cites W2155069330 @default.
• W2158752020 cites W2157806784 @default.
• W2158752020 cites W2160511242 @default.
• W2158752020 cites W2162674411 @default.
• W2158752020 cites W2172164484 @default.
• W2158752020 cites W2338895639 @default.
• W2158752020 cites W2397167021 @default.
• W2158752020 cites W2469424236 @default.
• W2158752020 cites W2797105966 @default.
• W2158752020 cites W2991939077 @default.
• W2158752020 cites W4231754696 @default.
• W2158752020 cites W4253543067 @default.
• W2158752020 cites W95159028 @default.
• W2158752020 doi "https://doi.org/10.1093/jnci/dju412" @default.
• W2158752020 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4326312" @default.
• W2158752020 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25540245" @default.
• W2158752020 hasPublicationYear "2014" @default.
• W2158752020 type Work @default.
• W2158752020 sameAs 2158752020 @default.
• W2158752020 citedByCount "16" @default.
• W2158752020 countsByYear W21587520202015 @default.
• W2158752020 countsByYear W21587520202016 @default.
• W2158752020 countsByYear W21587520202017 @default.
• W2158752020 countsByYear W21587520202019 @default.
• W2158752020 countsByYear W21587520202020 @default.
• W2158752020 countsByYear W21587520202021 @default.
• W2158752020 countsByYear W21587520202022 @default.
• W2158752020 countsByYear W21587520202023 @default.
• W2158752020 crossrefType "journal-article" @default.
• W2158752020 hasAuthorship W2158752020A5001373245 @default.
• W2158752020 hasAuthorship W2158752020A5027618882 @default.
• W2158752020 hasAuthorship W2158752020A5037848674 @default.

• next